Profile
Corporate information
Official name
Vivo Capital LLC
Registration country
Official name
Vivo Capital LLC
Registration country
Investment activity status
Active investor
Funds managed
Fund | Type | Vintage |
---|---|---|
Vivo Capital Fund VIII LP | Venture | 2015 |
Vivo Capital Surplus Fund VIII LP | Venture | 2015 |
Investments
Selected investments
Company | Country | Date | Notes | ||
---|---|---|---|---|---|
Ajax Therapeutics Inc Blood cancer biotech. |
United States | 13 May 2024 | Series C Initial investment. Round participant. Active |
||
Blossomhill Therapeutics Inc Biotechnology company focused on oncology and autoimmune disorders. |
United States | 4 Mar 2021 | Series A Initial investment. Round participant. Active |
||
Poseida Therapeutics Inc |
United States | 3 Apr 2018 22 Apr 2019 |
Series C Round participant. Active |
||
Tricida Inc |
United Kingdom | 15 Jul 2016 | Series C Led the investment round. Active |